Abstract
POSTER: AML-391 WHO and ICC 2022 Cytogenetic Abnormalities Defining Acute Myelogenous Leukemia (AML) Myelodysplasia-Related in First-Line Decitabine in Unfit AML Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have